Histological analysis of the ligamentum flavum of patients with dialysis-related spondyloarthropathy

Journal of Orthopaedic Science

Volumn 9, Issue 3, 2004, Pages 285-290

  Inatomi, Kenshiro ^a   Matsumoto, Tomoko ^a   Tomonaga, Tadashi ^a   Eto, Masao ^a   Shindo, Hiroyuki ^a   Hayashi, Tomayoshi ^a   Konishi, Hiroaki ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI ROSAI HOSPITAL   (Japan)

Author keywords

Advanced glycation end product 2 Microglobulin; Dialysis related spondyloarthropathy

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID; BETA 2 MICROGLOBULIN; CD68 ANTIGEN; CONGO RED;

ADULT; AGED; ARTICLE; CERVICAL SPINE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS RELATED SPONDYLOARTHROPATHY; DISABILITY; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAMENTUM FLAVUM; LONG TERM CARE; MACROPHAGE; MALE; PATHOPHYSIOLOGY; SPONDYLOARTHROPATHY;

EID: 3042546495     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-004-0767-6     Document Type: Article

References (20)

1. Araki N, Ueno N, Chakrabarti B, et al. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 1992;267:10211-4.
2. Danesh FR, Klinkmann J, Yokoo H, et al. Fatal cervical spondyloarthropathy in a hemodialysis patient with systemic deposition of beta2-microglobulin amyloid. Am J Kidney Dis 1999;33:563-6.
3. Fiocchi O, Bedani PL, Orzincolo C, et al. Radiological features of dialysis amyloid spondyloarthropathy. Int J Artif Organs 1989;12:216-22.
4. Floege J, Ketteler M. Beta2-microglobulin-derived amyloidosis: an update. Kidney Int Suppl 2001;78:S164-71.
5. Gejyo F, Yamada T, Odani S, et al. A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 1985;129:701-6.
6. Gejyo F, Odani S, Yamada T, et al. β-2 Microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986;30:385-90.
7. Jadoul M, Garbar C, Noël H, et al. Histological prevalence of β2-microglobulin amyloidosis in haemodialysis: a prospective post-mortem study. Kidney Int 1997;51:1928-32.
8. Kirstein M, Brett J, Radoff S, et al. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990;87:9010-4.
9. Kuntz D, Naveau B, Bardin T, et al. Destructive spondylarthropathy in hemodialyzed patients: a new syndrome. Arthritis Rheum 1984;27:369-75.
10. Makita Z, Vlassara H, Rayfield E, et al. Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science 1992;258:651-3.
11. Matsuo K, Ikizler TA, Hoover RL, et al. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis. Kidney Int 2000;57:697-708.
12. Miyata T, Oda O, Inagi R, et al. β2-Microblobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993;92:1243-52.
13. 2- microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J Clin Invest 1994;93:521-8.
14. Miyata T, Iida Y, Ueda Y, et al. Monocyte/macrophage response to β2 microglobulin modified with advanced glycation end products. Kidney Int 1996;49:538-50.
15. Moe SM, Singh GK, Bailey AM. beta2-microglobulin induces MMP-1 but not TIMP-1 expression in human synovial fibroblasts. Kidney Int 2000;57:2023-34.
16. Nokura K, Koga H, Yamamoto H, et al. Dialysis-related spinal canal stenosis: a clinicopathological study on amyloid deposition and its AGE modification. J Neurol Sci 2000;178:114-23.
17. Ohashi K, Hara M, Kawai R, et al. Cervical discs are most susceptible to beta2-microglobulin amyloid deposition in the vertebral column. Kidney Int 1992;41:1646-52.
18. Palinski W, Koschinsky T, Butler SW, et al. Immunological evidence for the presence of advanced glycation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler Thromb Vasc Biol 1995;15:571-82.
19. Smith MA, Taneda S, Richey PL, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 1994;91:5710-4.
20. Solé M, Munoz-Gümez J, Campistol JM. Role of amyloid in dialysis-related arthropathies: a morphological analysis of 23 cases. Virchows Arch A Pathol Anat 1990;417:523-8.